Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Jr.

Congressional Health Committee Leaders from Both Parties Write: ‘Vaccines Save Lives’

Washington, DC, February 23, 2017 — Jessie Hellmann reports in The Hill that top lawmakers from both parties are signing onto a bipartisan “Dear Colleague” letter to members of Congress to say that “vaccines save lives.”

While the letter did not mention President Trump, he has publicly questioned the effectiveness of vaccines and whether they are linked to autism.

The letter was signed by Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.), chairman and ranking member of the Senate’s health committee, respectively. Continue reading

Rep. Pallone Announces Biomedical Research Funding Critical to New Jersey with House Passage of 21st Century Cures

Frank Pallone flag

U.S. Rep. Frank Pallone, Jr. (D-6) serves as Ranking Member of the House Committee on Energy and Commerce

Washington, DC, July 13, 2015 ― With the House of Representatives’ passage of the 21st Century Cures Act on Friday, Congressman Frank Pallone, Jr. (NJ-06) announced biomedical research funding in the legislation to support progress toward treatments for rare diseases.

Congressman Pallone has played an integral role in leading the bill through the House as both a sponsor of the legislation and as the Ranking Member of the Energy and Commerce Committee.

The legislation provides a National Institutes of Health (NIH) funding boost to New Jersey and the state stands to benefit as a leader in drug manufacturing and biomedical research.  The bill passed the House by a 344 to 77 vote.

“21st Century Cures is a good bill for patients around the country and stands to be a very good bill for the State of New Jersey.  I am glad that our hard bipartisan work has paid off in the bill’s passage,” said Congressman Pallone. Continue reading